LOS ANGELES: Pipeline Insights provides an in-depth analysis of traumatic brain injury. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Traumatic Brain Injury Report helps to identify emerging players with potentially strong product Read More »

BOSTON: Investigators at Montefiore Health System and Albert Einstein College of Medicine of Yeshiva University claim “We are focusing on how the brain ages in the absence of disease, to provide a foundation for identifying the earliest features of Alzheimer’s disease. Early detection is key Read More »

CHICAGO: Although high blood pressure is a negative health condition that is to be avoided, having genes that increase the risk of hypertension may actually help to lower the risk of developing Alzheimer’s disease. In addition, a new study indicates that anti-hypertensive medication may also Read More »

LOS ANGELES: T3D Therapeutics, Inc., a Research Triangle Park, NC-based developer of Alzheimer’s disease therapies, announced today that the Division of Neurology Products of the U.S. Food and Drug Administration has approved the company’s Investigational New Drug (IND) application to begin a Phase 2a clinical study Read More »